senolytic peptide foxo4-dri human study Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells Molecular modelling of the FOXO4-TP53

Novo Nordisk executive president of development Martin Holst Lange recently told analysts he has confidence that the larger trials of the drug will show that CagriSema could help users lose up to 25% of their weight

Cinnarizine is used to help control motion sickness symptoms, so it is a useful product to keep on hand if travel regularly leaves you feeling unwell

Peptide therapy, stem cell therapy, and PRP therapy offer innovative solutions for treating shoulder injuries, rotator cuff injuries, and enhancing recovery

The Joint Research Ethics Committee of St Jamess and Tallaght Hospitals approved the study and written informed consent was obtained from all participants